Lin C F, Ho J L, Chung T C
Department of Veterinary Medicine, National Chung-Hsing University, Taichung, Taiwan, ROC.
Biosci Biotechnol Biochem. 2001 Jul;65(7):1495-503. doi: 10.1271/bbb.65.1495.
A 3.2 kb DNA fragment containing the replication region (RR) from pTC82 was cloned, sequenced, and found to contain elements typical of plasmids that replicate via a rolling-circle mechanism of replication (RCR), including double-strand origin (DSO), replication protein gene (rep), and single-strand origin (SSO). The DSO of pTC82 contains two domains showing 55.5% and 84.6% similarities in nucleotide (nt) sequence to the conserved functional elements bind and nic, respectively, which are required for the initiation of the leading strand typical of the pC194-RCR family. Although the predicted rep gene product of pTC82 (Rep82) shares little identity (less than 24%) with other known Reps, a region containing three motifs, characteristic of the pC194-family Reps, was identified, indicating the Rep82 as a novel Rep protein of this family. Downstream of the rep82 gene, strong similarity to the typical palT type-SSO could be detected. This is the first palT type-SSO to be identified from Lactobacillus. Through a series of deletion studies, the minimal replicon of the cloned RR was found to be 2.66 kb in size including the DSO region and rep gene. This RR was further identified as being highly stable in L. reuteri and also bearing a very narrow host-range property, suggesting it to be a good replicon potentially useful in vector construction for developing L. reuteri as a vaccine carrier.
克隆了一个包含来自pTC82复制区域(RR)的3.2 kb DNA片段,对其进行测序后发现,该片段包含通过滚环复制机制(RCR)进行复制的质粒的典型元件,包括双链起点(DSO)、复制蛋白基因(rep)和单链起点(SSO)。pTC82的DSO包含两个结构域,其核苷酸(nt)序列与保守功能元件bind和nic的相似性分别为55.5%和84.6%,这两个元件是pC194 - RCR家族典型的前导链起始所必需的。尽管预测的pTC82的rep基因产物(Rep82)与其他已知的Reps几乎没有同源性(不到24%),但鉴定出了一个包含三个基序的区域,这是pC194家族Reps的特征,表明Rep82是该家族的一种新型Rep蛋白。在rep82基因的下游,可以检测到与典型的palT型SSO有很强的相似性。这是首次从乳酸杆菌中鉴定出palT型SSO。通过一系列缺失研究,发现克隆的RR的最小复制子大小为2.66 kb,包括DSO区域和rep基因。进一步鉴定出该RR在罗伊氏乳杆菌中高度稳定,并且宿主范围非常狭窄,这表明它是一种很好的复制子,可能有助于构建载体,将罗伊氏乳杆菌开发为疫苗载体。